跳至主要内容
临床试验/ACTRN12615000668505
ACTRN12615000668505已完成不适用

Is intracytoplasmic morphologically selected sperm injection (IMSI) more effective than intracytoplasmic sperm injection (ISCI) in cases of severe oligo-astheno-teratozoospermia? A prospective study regarding pregnancy outcome

alexandria university, faculty of medicne0 个研究点目标入组 1,729 人开始时间: 2015年6月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,729

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
25 Years 至 45 Years(—)
性别
All

入选标准

  • very poor semen quality characterized by severe oligo-astheno-teratozoospermia (sperm concentration less than 5 million per ml, less than 50% motile sperms according to WHO criteria and less than 14% morphologically normal spermatozoa according to the Strict Kruger Criteria), a normal karyotype in both partners

排除标准

  • Uterine defects, hydrosalpinx, endometriosis, polycystic ovaries, evidence of low ovarian response in previous treatment cycles (less than four oocytes retrieved), infections, endocrinal problems, coagulation defects or thrombophilia and autoimmune defects (including antiphospholipid antibodies) were all excluded.

研究者

发起方
alexandria university, faculty of medicne

相似试验